Can we conclude a potential therapeutic action for Parkinson’s disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?
Crossref DOI link: https://doi.org/10.1038/s41419-018-0798-0
Published Online: 2018-07-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Segura-Aguilar, Juan http://orcid.org/0000-0002-1018-673X
Text and Data Mining valid from 2018-07-03
Version of Record valid from 2018-07-03
Article History
Received: 3 May 2018
Accepted: 14 June 2018
First Online: 3 July 2018
Conflict of interest
: The author declares no conflict of interest.